Coiled-coil-helix-coiled-coil-helix domain containing 1 (CHCHD1) is a mitochondrial protein involved in oxidative phosphorylation and mitochondrial protein synthesis. While its functions have been explored in basic mitochondrial biology, the role of this process in hepatocellular carcinoma (HCC) remains poorly understood.
Materials and Methods:
We performed transcriptomic analysis on 272 HCC and 50 normal liver tissue samples to assess CHCHD1 expression. Correlations with clinical features were analyzed using Pearson coefficients. Prognostic relevance was evaluated using receiver operating characteristic analysis. Functional studies in SMMC-7721 cells included transwell migration/invasion assays, as well as western blotting, to assess epithelial–mesenchymal transition (EMT) markers and transforming growth factor (TGF)-β1 signaling. Gene set enrichment analysis (GSEA), single-cell RNA sequencing (scRNA-seq), and immune infiltration analyses were conducted to investigate immunoregulatory functions.
Results:
CHCHD1 expression was significantly upregulated in HCC tissues (1.38-fold, p < 0.001) and correlated positively with tumor size (R = 0.45), vascular invasion (R = 0.56), and advanced Barcelona Clinic Liver Cancer stage (R = 0.62; all p < 0.001). High CHCHD1 predicted shorter progression-free survival (area under the curve = 0.938; 95% confidence interval 0.910–0.965; p = 0.039). Overexpression of CHCHD1 enhanced cell migration and invasion, promoted EMT (downregulation of E-cadherin and upregulation of vimentin), and activated TGF-β1 signaling. GSEA linked CHCHD1 to immune-related pathways. scRNA-seq localized CHCHD1 to myeloid-derived suppressor cells, showing potential interactions with TGF-β receptor 1. CHCHD1 expression correlated with Th2 cell infiltration (R = 0.57, p = 0.025) and programmed cell death 1 expression (p = 0.027).
Conclusion:
CHCHD1 promotes EMT and immune evasion in HCC via TGF-β1 signaling, implicating it as a promising biomarker and therapeutic target.
Get full access to this article
View all access options for this article.
References
1.
AbutalebiM, LiD, AhmadW, et al.Discovery of PELATON links to the INHBA gene in the TGF-β pathway in colorectal cancer using a combination of bioinformatics and experimental investigations. Int J Biol Macromol, 2024; 270(Pt 1):132239.
2.
BrayF, FerlayJ, SoerjomataramI, et al.Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 2018; 68(6):394–424; doi: 10.3322/caac.21492
3.
ColapricoA, SilvaTC, OlsenC, et al.TCGAbiolinks: An R/Bioconductor package for integrative analysis of TCGA data. Nucleic Acids Res, 2016; 44(8):e71; doi: 10.1093/nar/gkv1507
4.
Di CeglieI, CarnevaleS, RigatelliA, et al.Immune cell networking in solid tumors: Focus on macrophages and neutrophils. Front Immunol, 2024; 15:1341390; doi: 10.3389/fimmu.2024.1341390
5.
ESHRE. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod, 2004; 19(1):41–47; doi: 10.1093/humrep/deh098
6.
FanY, MuJ, HuangM, et al.Epigenetic identification of ADCY4 as a biomarker for breast cancer: An integrated analysis of adenylate cyclases. Epigenomics, 2019; 11(14):1561–1579; doi: 10.2217/epi-2019-0207
7.
FjeldboCS, AarnesEK, MalinenE, et al.Identification and validation of reference genes for RT-qPCR studies of hypoxia in squamous cervical cancer patients. PLoS One, 2016; 11(5):e0156259; doi: 10.1371/journal.pone.0156259
GiannelliG, KoudelkovaP, DituriF, et al.Role of epithelial to mesenchymal transition in hepatocellular carcinoma. J Hepatol, 2016; 65(4):798–808; doi: 10.1016/j.jhep.2016.05.007
10.
GreenwaldRJ, FreemanGJ, SharpeAH. The B7 family revisited. Annu Rev Immunol, 2005; 23:515–548; doi: 10.1146/annurev.immunol.23.021704.115611
11.
HabibzadehG, MokhtariK, HeshmatiM, et al.Identification of lncRNA associated with the SERPINE1 gene in colorectal cancer through TGF-β pathway. Comput Biol Med, 2025; 190:110037; doi: 10.1016/j.compbiomed.2025.110037
12.
HachemS, YehyaA, El MasriJ, et al.Contemporary update on clinical and experimental prostate cancer biomarkers: A multi-omics-focused approach to detection and risk stratification. Biology (Basel), 2024; 13(10):762; doi: 10.3390/biology13100762
13.
HanQ, LvL, WeiJ, et al.Vps4A mediates the localization and exosome release of beta-catenin to inhibit epithelial-mesenchymal transition in hepatocellular carcinoma. Cancer Lett, 2019; 457:47–59; doi: 10.1016/j.canlet.2019.04.035
14.
HarbauerAB, ZahediRP, SickmannA, et al.The protein import machinery of mitochondria-a regulatory hub in metabolism, stress, and disease. Cell Metab, 2014; 19(3):357–372; doi: 10.1016/j.cmet.2014.01.010
15.
HatoT, GoyalL, GretenTF, et al.Immune checkpoint blockade in hepatocellular carcinoma: Current progress and future directions. Hepatology, 2014; 60(5):1776–1782; doi: 10.1002/hep.27246
16.
HeerbothS, HousmanG, LearyM, et al.EMT and tumor metastasis. Clin Transl Med, 2015; 4:6; doi: 10.1186/s40169-015-0048-3
17.
HeggiMT, Nour El-DinHT, MorsyDI, et al.Microbial evasion of the complement system: A continuous and evolving story. Front Immunol, 2023; 14:1281096; doi: 10.3389/fimmu.2023.1281096
18.
HigginsJP, ThompsonSG, DeeksJJ, et al.Measuring inconsistency in meta-analyses. Bmj, 2003; 327(7414):557–560; doi: 10.1136/bmj.327.7414.557
19.
ImaniS, WeiC, ChengJ, et al.MicroRNA-34a targets epithelial to Mesenchymal Transition-Inducing Transcription Factors (EMT-TFs) and inhibits breast cancer cell migration and invasion. Oncotarget, 2017; 8(13):21362–21379; doi: 10.18632/oncotarget.15214
20.
KaoJH, ChenDS. Changing disease burden of hepatocellular carcinoma in the Far East and Southeast Asia. Liver Int, 2005; 25(4):696–703; doi: 10.1111/j.1478-3231.2005.01139.x
21.
KocEC, CimenH, KumcuogluB, et al.Identification and characterization of CHCHD1, AURKAIP1, and CRIF1 as new members of the mammalian mitochondrial ribosome. Front Physiol, 2013; 4:183; doi: 10.3389/fphys.2013.00183
22.
KoyasuS, MoroK. Type 2 innate immune responses and the natural helper cell. Immunology, 2011; 132(4):475–481; doi: 10.1111/j.1365-2567.2011.03413.x
23.
KuleshovMV, JonesMR, RouillardAD, et al.Enrichr: A comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res, 2016; 44(W1):W90–W97.
24.
LeeSC, TanHT, ChungMC. Prognostic biomarkers for prediction of recurrence of hepatocellular carcinoma: Current status and future prospects. World J Gastroenterol, 2014; 20(12):3112–3124; doi: 10.3748/wjg.v20.i12.3112
25.
LiT, FuJ, ZengZ, et al.TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res, 2020; 48(W1):W509–W514; doi: 10.1093/nar/gkaa407
26.
LinX, KangK, ChenP, et al.Regulatory mechanisms of PD-1/PD-L1 in cancers. Mol Cancer, 2024; 23(1):108; doi: 10.1186/s12943-024-02023-w
27.
LiuJ, OlyaeeY, MokhtariK, et al.The role of the TIMP1/LINC01615 axis as a regulator of the EMT pathway in gastric cancer. Biol Proced Online, 2025; 27(1):31; doi: 10.1186/s12575-025-00297-y
LivakKJ, SchmittgenTD. ST. Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C (T)) method. Methods, 2001; 25(4):402–408.
MengY, ZhangM, LiX, et al.Myeloid cell-expressed MNDA enhances M2 polarization to facilitate the metastasis of hepatocellular carcinoma. Int J Biol Sci, 2024; 20(8):2814–2832; doi: 10.7150/ijbs.91877
32.
MermelCH, SchumacherSE, HillB, et al.GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol, 2011; 12(4):R41; doi: 10.1186/gb-2011-12-4-r41
33.
MiaoY, WangJ, LiQ, et al.Prognostic value and immunological role of PDCD1 gene in pan-cancer. Int Immunopharmacol, 2020; 89(Pt B):107080; doi: 10.1016/j.intimp.2020.107080
34.
ModjtahediN, TokatlidisK, DessenP, et al.Mitochondrial proteins containing Coiled-Coil-Helix-Coiled-Coil-Helix (CHCH) domains in health and disease. Trends Biochem Sci, 2016; 41(3):245–260; doi: 10.1016/j.tibs.2015.12.004
35.
NakaeS, SutoH, IikuraM, et al.Mast cells enhance T cell activation: Importance of mast cell costimulatory molecules and secreted TNF. J Immunol, 2006; 176(4):2238–2248; doi: 10.4049/jimmunol.176.4.2238
36.
NorouzinasabF, SalimianN, MokhtariK, et al.Discovery of LINC01614 associated with the SPP1 gene in colorectal cancer. Pathol Res Pract, 2025; 266:155761; doi: 10.1016/j.prp.2024.155761
37.
OkazakiT, HonjoT. The PD-1-PD-L pathway in immunological tolerance. Trends Immunol, 2006; 27(4):195–201; doi: 10.1016/j.it.2006.02.001
38.
PaduaD, MassagueJ. Roles of TGFbeta in metastasis. Cell Res, 2009; 19(1):89–102; doi: 10.1038/cr.2008.316
39.
RenXP, LiRK. Standardized screening and early imaging diagnosis strategies for hepatocellular carcinoma. Zhonghua Gan Zang Bing Za Zhi, 2021; 29(4):304–307; doi: 10.3760/cma.j.cn501113-20210406-00164
40.
SalehR, ToorSM, Al-AliD, et al.Blockade of PD-1, PD-L1, and TIM-3 altered distinct immune- and cancer-related signaling pathways in the transcriptome of human breast cancer explants. Genes (Basel), 2020; 11(6):703; doi: 10.3390/genes11060703
41.
SoukupovaJ, MalfettoneA, BertranE, et al.Epithelial-Mesenchymal Transition (EMT) induced by TGF-β in hepatocellular carcinoma cells reprograms lipid metabolism. Int J Mol Sci, 2021; 22(11):5543; doi: 10.3390/ijms22115543
ThomasLW, EspositoC, StephenJM, et al.CHCHD4 regulates tumour proliferation and EMT-related phenotypes, through respiratory chain-mediated metabolism. Cancer Metab, 2019; 7:7; doi: 10.1186/s40170-019-0200-4
44.
WangM, ZengQ, LiY, et al.Bevacizumab combined with apatinib enhances antitumor and anti-angiogenesis effects in a lung cancer model in vitro and in vivo. J Drug Target, 2020; 28(9):961–969; doi: 10.1080/1061186X.2020.1764963
45.
WangS, HeY, WangJ, et al.Re-exploration of immunotherapy targeting EMT of hepatocellular carcinoma: Starting from the NF-κB pathway. Biomed Pharmacother, 2024; 174:116566; doi: 10.1016/j.biopha.2024.116566
46.
WestermanBA, PoutsmaA, SteegersEA, et al.C2360, a nuclear protein expressed in human proliferative cytotrophoblasts, is a representative member of a novel protein family with a conserved coiled coil-helix-coiled coil-helix domain. Genomics, 2004; 83(6):1094–1104; doi: 10.1016/j.ygeno.2003.12.006
47.
WuST, ZhuL, FengXL, et al.Strategies for discovering novel hepatocellular carcinoma biomarkers. World J Hepatol, 2025; 17(2):101201; doi: 10.4254/wjh.v17.i2.101201
48.
WuY, ZhouBP. New insights of epithelial-mesenchymal transition in cancer metastasis. Acta Biochim Biophys Sin (Shanghai), 2008; 40(7):643–650; doi: 10.1111/j.1745-7270.2008.00443.x
49.
XuWH, ShiSN, XuY, et al.Prognostic implications of Aquaporin 9 expression in clear cell renal cell carcinoma. J Transl Med, 2019; 17(1):363; doi: 10.1186/s12967-019-2113-y
50.
YangQ, NiL, ImaniS, et al.Anlotinib suppresses colorectal cancer proliferation and angiogenesis via inhibition of AKT/ERK signaling cascade. Cancer Manag Res, 2020; 12:4937–4948; doi: 10.2147/CMAR.S252181
51.
YangY, YeYC, ChenY, et al.Crosstalk between hepatic tumor cells and macrophages via Wnt/β-catenin signaling promotes M2-like macrophage polarization and reinforces tumor malignant behaviors. Cell Death Dis, 2018; 9(8):793; doi: 10.1038/s41419-018-0818-0
52.
YaoY, SuJ, ZhaoL, et al.CHCHD2 promotes hepatocellular carcinoma and indicates poor prognosis of hepatocellular carcinoma patients. J Cancer, 2019; 10(27):6822–6828; doi: 10.7150/jca.31158
53.
YinX, XiaJ, SunY, et al.CHCHD2 is a potential prognostic factor for NSCLC and is associated with HIF-1a expression. BMC Pulm Med, 2020; 20(1):40; doi: 10.1186/s12890-020-1079-0
54.
ZamoraJ, AbrairaV, MurielA, et al.Meta-DiSc: A software for meta-analysis of test accuracy data. BMC Med Res Methodol, 2006; 6:31; doi: 10.1186/1471-2288-6-31
55.
ZhangQ, HeY, LuoN, et al.Landscape and dynamics of single immune cells in hepatocellular carcinoma. Cell, 2019; 179(4):829–845.e820; doi: 10.1016/j.cell.2019.10.003
56.
ZhengK, HaiY, ChenH, et al.Tumor immune dysfunction and exclusion subtypes in bladder cancer and pan-cancer: A novel molecular subtyping strategy and immunotherapeutic prediction model. J Transl Med, 2024; 22(1):365; doi: 10.1186/s12967-024-05186-8
57.
ZhouZD, SawWT, TanEK. Mitochondrial CHCHD-Containing proteins: Physiologic functions and link with neurodegenerative diseases. Mol Neurobiol, 2017; 54(7):5534–5546; doi: 10.1007/s12035-016-0099-5
58.
ZouL, ImaniS, MaghsoudlooM, et al.Genomewide copy number analysis of circulating tumor cells in breast cancer patients with liver metastasis. Oncol Rep, 2020; 44(3):1075–1093; doi: 10.3892/or.2020.7650
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
